After watching this recent presentation by Leslie I am again impressed with her no nonsense style and solid representation of the facts. I like the way she just says what she can, without too much fang flashing and Disallowed, and knows her subject matter intimately and thoroughly.
She has assembled and heads up an experienced team with a proven track record in getting treatments into peoples arms and we just need to hold on till they can do it again, both for the patients and for us, who have put our dollars on the line.
When asked she replied there were 3 quarters of funding left after accounting for the two tax refunds owed them and the reduced spend from the previous period which was inflated by the manufacturing facility deal.
Nobody in their right mind, apart from the shorter's and would be manipulators, are happy to see the share price decreasing, but it's just how it is atm and as long as the company is a going concern with prospects, it will be played with and pushed, both up, and down, by various entities with both the clout and longer time frame perspective.
We retail can't play those games, only be aware of them, and exercise our buy, hold or sell response as we see fit, and in accordance with our individual circumstances.
Having had my own personal brush with cancer and having seen its effect in the lives of family and friends I hope she and Imugene are successful in their endeavour to thwart this scourge to humanity.
GLTAH
IMU Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)